Section Arrow
Quote
BDSX.NASDAQ
- Biodesix
(Financial Status)
Quotes are at least 15-min delayed:2025/07/03 11:53 EDT
Last
 0.2764
+0.0014 (+0.51%)
Day High 
0.29 
Prev. Close
0.275 
1-M High
0.33 
Volume 
349.11K 
Bid
0.2754
Ask
0.2775
Day Low
0.27 
Open
0.2873 
1-M Low
0.25 
Market Cap 
40.30M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.27 
20-SMA 0.29 
50-SMA 0.35 
52-W High 2.04 
52-W Low 0.1718 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.27/-0.15
Enterprise Value
101.54M
Balance Sheet
Book Value Per Share
0.08
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
71.32M
Operating Revenue Per Share
0.30
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
NEOGNeogen Corp5.285+0.055+1.05%879PE
PSNLPersonalis7.415-0.09-1.20%-- 
EXASExact Sciences Corp53.66-0.2-0.37%-- 
GRALGRAIL Inc.46.41-1.15-2.42%-- 
TMOThermo Fisher Scientific427.54-0.22-0.05%25.16PE
Quotes are at least 15-min delayed：2025/07/03 11:53 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.